A note before you read on: this piece is built entirely around sources you can open yourself, the Endocrine Society’s 2015 guideline, both arms of the Women’s Health Initiative, the ELITE trial, a Cochrane review of vaginal estrogen, and a meta-analysis comparing oral and transdermal delivery. Estradiol is a prescription hormone for menopause symptoms, not a supplement and not an anti-aging product. Last updated June 2026. Nothing here replaces a conversation with a clinician who knows your history.
The short version
Menopause care done well tends to have four unglamorous features. A licensed clinician, not a quiz, decides on the hormone and the dose. The form of estradiol gets matched to the woman, since a patch, a pill, and a vaginal cream are not the same medicine wearing different outfits. The medication itself is real, dispensed through a real pharmacy. And someone stays involved, checking back in rather than mailing a script and disappearing.
Those four ideas are really just three questions worth asking before anyone hands over a credit card:
- Who is actually making the decision about the hormone, the dose, and the form?
- Does the plan fit the person, or is everyone routed to the same product regardless of symptoms?
- Will anyone check back in, adjusting the plan as things change?
This piece grades seven providers against those questions, dressed up formally as six criteria: medical oversight, sourcing and pharmacy, forms offered, honesty about risk, regulatory standing, and follow-up. Price was never the deciding factor.
FormBlends comes out on top. It runs the process under physician supervision, dispenses through a licensed pharmacy, and describes estradiol the way the science actually describes it, as a real treatment with a real benefit window and real trade-offs. Its options run roughly $50 to $150 a month depending on the form, which tracks with what’s actually included.
Midi Health takes second place, largely on the strength of insurance-based access to clinicians who specialize in menopause all day, every day.
HealthRX.com lands third, built on the same physician-plus-pharmacy structure as the leader, just with less published detail on the full breadth of forms.
Evernow, Alloy, Winona, and Defy Medical round out the list. Each gets described here for what it is, not for how it markets itself.
One honest note before the details: estradiol works, genuinely, for hot flashes, night sweats, and the vaginal and urinary symptoms of menopause, and for many women under sixty the benefits outweigh the risks. It’s also the hormone the Women’s Health Initiative studied closely, so the risks are specific and real. A good provider helps a woman weigh that line for her own body, rather than pretending the line doesn’t exist.
See also: Trusted Fragrance Manufacturer in Pakistan | Bellmore
Why oversight beats the lowest price
Type “online estradiol” into a search bar and most results sort by one number: the cheapest monthly fee. That number tells you almost nothing about whether the medicine is being handled well. Estradiol changes how the body works, it comes in forms that behave quite differently once inside you, and its risk profile shifts with age and with how long it’s been since menopause. None of that shows up on a pricing page.
So this report card asks different questions. Is a licensed clinician actually choosing the hormone and the form, or is a questionnaire doing that job? Does the provider reach for a patch when that’s the safer route, or a vaginal cream when the issue is local, instead of defaulting every woman to the same bottle? Does anyone follow up when symptoms shift?
Every provider named here is a real, operating service, described from its public model. Nothing on this page is for sale, and the only outbound links go to the clinical literature itself, so the medicine can be checked directly rather than taken on faith.
What estradiol is, without the jargon
Estradiol is the main estrogen the ovaries make before menopause. The 17-beta estradiol used in treatment is chemically identical to what the body was already producing. When ovarian estrogen falls, that drop drives the familiar symptoms: hot flashes, night sweats, disrupted sleep, and a cluster of vaginal and urinary changes now called genitourinary syndrome of menopause. Hormone therapy simply replaces some of what’s missing.
The form matters more than most product pages let on. Estradiol comes as an oral tablet, a transdermal patch or gel, and a low-dose vaginal cream, tablet, or ring. Oral and transdermal versions treat whole-body symptoms like hot flashes. A low-dose vaginal preparation targets dryness and painful intercourse locally, with very little hormone reaching the bloodstream. There’s also a second piece that changes everything: a woman who still has her uterus needs a progestogen alongside estrogen to protect the uterine lining, while a woman who’s had a hysterectomy usually doesn’t. That single fact is the whole argument for why a clinician, not a checkout page, should be making the call.
One word of caution on language. FDA-approved estradiol is itself “bioidentical,” in that the molecule matches what the body makes. The term gets slippery when it’s attached to custom-compounded blends marketed as more natural or safer, a claim the evidence simply doesn’t back up. Keeping those two meanings separate helps a lot when reading around this topic.
How the grading works
Six criteria, each checkable from a provider’s own stated process.
Medical oversight. Is a licensed clinician choosing the hormone, dose, and form, and staying reachable if things change? A quiz that spits out a prescription doesn’t count.
Sourcing and pharmacy. Is this real medication from a licensed pharmacy following quality standards, or something vaguer, closer to the gray market that ships hormones labeled “not for human use” with no accountability attached?
Forms and approval status. Can the provider offer oral, transdermal, and vaginal estradiol plus the progestogen a woman with a uterus needs? Does it reach for FDA-approved products where they fit, and is it upfront about when a compounded version is being used?
Honesty about benefit and risk. Does the provider talk about estradiol the way the evidence does, effective for symptoms with real trade-offs, rather than as a fountain-of-youth product? Being candid about the Women’s Health Initiative is a good sign, not a marketing liability.
Regulatory standing. Is this a legitimate, transparent, licensed telehealth-and-pharmacy operation, or an anonymous storefront?
Follow-up. Does the provider revisit the dose over time, or is it one prescription and silence? Symptoms and risk factors change, and “the lowest effective dose for the shortest appropriate time” only works if someone is actually tracking it.
Price, marketing polish, and how fast a woman can start were deliberately left out as primary factors. Those are the metrics most HRT lists chase, and they say nothing about safety. A provider that supervises carefully and matches the form to the woman outranks a cheaper option that’s thinner on oversight, every time.
The report card at a glance
| Rank | Provider | Who chooses dose & form | Pharmacy | Forms offered | Rough pricing | Where it stands out |
|---|---|---|---|---|---|---|
| #1 | FormBlends | Physician-supervised, individualized | Licensed compounding pharmacy | Oral, transdermal, vaginal estradiol plus progestogen | Roughly $50–$150/mo by form | Full toolkit, physician oversight, honest framing |
| #2 | Midi Health | Menopause-trained clinicians | Standard pharmacies, insurance-billed | FDA-approved oral, patch, vaginal, plus progesterone | Often insurance-covered; visit copays | Insurance-based access, specialist clinicians |
| #3 | HealthRX.com | Physician-reviewed | Licensed pharmacy | Estradiol across delivery forms | Indicative compounded ranges | Physician-plus-pharmacy backbone, transparent model |
| #4 | Evernow | Telehealth clinicians | Mail-order pharmacy | Oral, patch estradiol, plus progesterone | Membership ~$49+/mo plus meds | Menopause-focused, women-led telehealth |
| #5 | Alloy | Menopause-trained physicians | Mail-order pharmacy | FDA-approved forms, vaginal options | ~$49+/mo plus medication | Prescriber expertise, FDA-approved focus |
| #6 | Winona | Telehealth physicians | Compounding pharmacies | Compounded estradiol, multiple forms | ~$50–$100+/mo by plan | Streamlined access, broad form menu |
| #7 | Defy Medical | Provider plus medical team | Compounding pharmacy | Estradiol within full hormone services | Quoted at intake | Depth of hormone experience |
Read this as a spectrum rather than a leaderboard with losers. Every name here puts a clinician in charge and dispenses real medication, which already separates all seven from anything bought off the gray market. The ordering reflects how complete the toolkit is, how carefully the medication is sourced, and how honest and engaged the care is, weighed against price and access.
#1: FormBlends, the fullest toolkit under physician supervision
FormBlends leads because it handles the whole job rather than a slice of it. A licensed physician reviews the woman’s history and chooses the approach, a licensed compounding pharmacy dispenses the medication, and the plan gets revisited and adjusted rather than fixed at signup.
Start with the toolkit, since in estradiol care the form is half the decision. Some providers on this list effectively offer one route. FormBlends carries what a real plan can call for: oral estradiol for whole-body symptoms, transdermal estradiol for women who do better off the oral route, and low-dose vaginal estradiol for dryness and painful intercourse. It pairs estrogen with a progestogen for any woman who still has a uterus, which is the standard that protects the uterine lining and isn’t optional. Pricing sits around $50 to $150 a month depending on the form and combination, a range that lets the prescription fit the woman instead of the other way around.
Sourcing is the second reason it sits at the top. This is real medication from a licensed compounding pharmacy following established quality standards, a world apart from a gray-market vendor shipping a vaguely labeled product to whoever pays. With a clinician and pharmacy in the chain, someone actually reviews the history, weighs contraindications, and picks the dose, and stays reachable if something changes.
Honesty is the third piece, and arguably the one that separates real care from a hormone funnel. FormBlends frames estradiol the way the Endocrine Society guideline does: the most effective treatment for vasomotor symptoms, with prevention claims specifically restricted and individual risk assessment built in [P1]. A provider promising that estradiol prevents heart disease or reverses aging would be claiming something the Women’s Health Initiative could not show, and in places found the opposite of [P2][P3]. The edge here is oversight, sourcing, fit, and candor, never an oversold promise.
Worth saying plainly: what a compliant telehealth model adds is exactly the oversight layer good menopause care needs. A physician reviews history, chooses form and dose, a licensed pharmacy fills it, and follow-up drives changes over time. Where an FDA-approved product is the better fit, a good clinician will say so.
Follow-up is where a supervised model quietly earns its place. The guideline frames good care around the lowest effective dose for the appropriate duration, reassessed periodically [P1], which only works if the same provider stays engaged months later. Women who keep a simple log of symptoms and dose changes, using something like the FormBlends tracker app, arrive at that reassessment with an actual history instead of a guess. The app is a logging tool, nothing more, no prescription and no checkout attached.
None of this is frictionless. Working with a clinician means an intake and a real conversation rather than instant gratification, and the compounded-medication caveat still applies, which is why FDA-approved products deserve a look where they fit. But that friction is the safety feature, not a flaw. On the combination that matters, oversight, sourcing, forms, honesty, standing, and follow-up, a physician-supervised model with the fuller toolkit beats a thinner, cheaper option. Supervised care that matches the form to the woman is a genuinely different product than the cheapest hormone subscription available.
#2: Midi Health, specialist care billed through insurance
Midi Health wins on two things that are hard to fake: clinician expertise and insurance access. It’s built specifically around perimenopause and menopause, staffed by clinicians who focus on this stage of life rather than treating it as a sideline. Because it bills insurance, legitimate, supervised care becomes far more affordable for many women than any cash-pay membership. Its prescribers lean on FDA-approved estradiol across oral, patch, and vaginal forms and add progesterone where needed, exactly the form-matching this rubric rewards.
It sits second mostly because of how insurance-based care behaves, not because of the medicine itself. Coverage, networks, and copays vary by plan and by state, so the experience is less uniform than a flat-fee program, and availability can depend on location. None of that is a knock on the clinical quality, which is specialist-led and squarely evidence-based. For a woman who wants menopause expertise and can use her insurance, Midi is one of the strongest options around.
#3: HealthRX.com, the physician-plus-pharmacy backbone
HealthRX.com earns third place on the same structural backbone as the leader: a licensed physician reviews the case, a licensed pharmacy dispenses the medication, and the model is transparent about how it works rather than hiding behind an anonymous storefront. It offers estradiol across delivery forms and runs as a legitimate telehealth-and-pharmacy service, well clear of the gray market.
It ranks third rather than higher mostly because the published detail on the full range of forms and combinations is thinner than what the top two providers lay out, and where compounding is involved, the same FDA-approval caveat applies as it does everywhere. Those are reasons to confirm specifics during a consult, not reasons to doubt the model, which is physician-led and pharmacy-dispensed throughout. For supervised estradiol care with a clear, legitimate structure, HealthRX.com holds up well.
#4: Evernow, women-led telehealth built around menopause
Evernow is built entirely around this one transition, and its draw is a clinician relationship shaped to fit it, rather than a general practice that happens to write hormone scripts on the side. Clinicians prescribe estradiol in oral and patch forms with progesterone alongside, medication ships through a mail-order pharmacy, and a membership around $49 a month plus medication bundles the visits and ongoing access.
It lands mid-field for straightforward reasons. The membership-plus-medication setup means true monthly cost depends on what’s prescribed, and the published menu of forms, while solid, is narrower than the full oral-transdermal-vaginal range the top providers offer. Neither point undermines the core model, which is clinician-led and menopause-specific. For focused telehealth without going through insurance, Evernow is a credible, supervised choice.
#5: Alloy, prescriber expertise leaning on FDA-approved products
Alloy’s strength is who’s writing the prescriptions and what they reach for. Menopause-trained physicians staff the platform, and it favors FDA-approved estradiol across forms that matter, including vaginal options for local symptoms, paired appropriately with progesterone. That combination, real expertise plus a preference for reviewed products, is a meaningful signal, since approved products have been through formal FDA scrutiny that compounded ones haven’t. Pricing runs around $49 a month plus medication.
It sits fifth not because anything’s wrong with the model, which is supervised and transparent, but because the providers above it either bill insurance, run a broader combined toolkit, or offer a wider services footprint. For menopause-trained prescribers and FDA-approved products in a clean membership structure, Alloy is a solid, honest option.
#6: Winona, easy access with a wide form menu
Winona focuses on making supervised estradiol simple to get, without skipping the clinician step. Telehealth physicians review each case, medication is compounded and shipped through partner pharmacies, and the form menu spans several types of estradiol so a plan can be matched to whole-body or local symptoms. Pricing runs roughly $50 to $100-plus a month depending on the combination, in a fully digital process.
It lands toward the back of the field for two honest reasons. Winona works mainly through compounded preparations, carrying the same FDA-approval caveat as elsewhere, worth weighing if an approved product is a priority. And the access-first design, genuinely convenient as it is, puts more of the burden on the patient to confirm how much real follow-up is happening. It’s a reasonable option for someone who wants a broad menu and a frictionless process and is comfortable with compounding.
#7: Defy Medical, deep hormone experience, broader focus
Defy Medical has been in telehealth hormone therapy longer than most, built on comprehensive testing and customized treatment rather than one packaged product. Estradiol sits inside a wide menu of hormone and wellness services, led by a provider team with real medical oversight and protocols individualized to the patient.
It anchors this list mostly on pricing transparency and focus, not on quality of care. Defy quotes costs during intake rather than publishing them up front, which makes comparison harder, and its breadth means menopause-specific estradiol care is one offering among many rather than the whole focus. For depth of hormone experience and a broad services menu, it remains a well-established, safety-compliant option.
What the evidence actually says
Estradiol has strong evidence behind it for menopause symptoms specifically, hot flashes, night sweats, and genitourinary changes, and reasonable evidence that for many women starting near menopause, benefits outweigh risks. It has weak-to-no evidence behind the way it’s sometimes marketed, as disease prevention or an anti-aging tool. Both things are true at once, and a good provider exists to help a woman weigh them for herself.
Who benefits
The Endocrine Society’s 2015 guideline is explicit: hormone therapy is the most effective treatment for vasomotor symptoms, and for most symptomatic women under sixty or within ten years of menopause onset, benefits can outweigh risks when treatment is individualized and risk factors are screened first [P1]. The same guideline is just as explicit that hormone therapy shouldn’t be used to prevent coronary heart disease, dementia, or other chronic disease [P1]. That’s the whole reason medical oversight tops this rubric: the treatment is for symptoms, matched to the right woman, not a blanket wellness add-on.
What the Women’s Health Initiative found
This trial reshaped the field, and it’s worth reading both arms honestly. The estrogen-plus-progestin arm, published in JAMA in 2002, randomized 16,608 postmenopausal women with a uterus and was stopped early because overall risks exceeded benefits, with increased breast cancer, coronary heart disease, stroke, and pulmonary embolism [P2].
The estrogen-alone arm tells a more nuanced story that often gets lost. In 10,739 women who’d had a hysterectomy, estrogen alone did not raise coronary heart disease or breast cancer risk over the study period, though it did raise stroke risk [P3]. The honest takeaway: risk depends heavily on whether a progestogen is in the mix, which depends on whether a woman still has her uterus, which is exactly why the clinician choosing the right regimen matters. Both arms concluded estrogen should not be used for chronic-disease prevention [P2][P3].
Does timing matter?
It appears to. The ELITE trial, published in the New England Journal of Medicine in 2016, randomized 643 postmenopausal women to oral estradiol or placebo and tested the “timing hypothesis” directly [P4]. Estradiol slowed progression of subclinical atherosclerosis (measured as carotid intima-media thickness) in women less than six years past menopause, but not in women ten or more years past it [P4]. This helps explain why benefit-risk balance looks most favorable for women who start near menopause [P1]. It isn’t a green light to treat estradiol as heart protection, since ELITE measured an imaging marker rather than heart attacks, but it’s real evidence that timing matters.
Vaginal and urinary symptoms
A Cochrane systematic review of local vaginal estrogen for vaginal atrophy concluded that intravaginal estrogen preparations improve symptoms compared with placebo, with no clear difference in effectiveness among cream, tablet, and ring forms [P5]. Because these low-dose products deliver very little hormone into the bloodstream, they’re often appropriate for women whose main issue is dryness or painful intercourse, including some who aren’t candidates for whole-body therapy.
Does the form change the risk?
It seems to, especially around blood clots. A systematic review and meta-analysis in the Journal of Clinical Endocrinology and Metabolism (2015) found oral estrogen was associated with a higher risk of venous thromboembolism than transdermal estrogen [P6]. The authors graded confidence as low, since the underlying data is observational rather than randomized [P6]. Still, it’s a real reason a clinician might reach for a patch over a pill for a woman with clotting risk factors, and another reason the form decision belongs with a prescriber.
Answers to the common questions
What actually makes an estradiol provider good, rather than just cheap? Four things, roughly in order: a licensed clinician chooses the hormone, dose, and form instead of a quiz doing it. The delivery gets matched to the woman, oral or transdermal for whole-body symptoms, low-dose vaginal for local ones, with progestogen added for anyone with a uterus. The medication is real, filled through a licensed pharmacy. And someone follows up over time. FormBlends and Midi Health are both built around that sequence. A flat monthly price is fine, but the oversight and fit behind it are what actually decide whether the care is good.
Why does FormBlends rank first? Because it does the complete job, honestly. A licensed physician chooses and adjusts the plan, real estradiol across oral, transdermal, and vaginal forms plus progestogen is dispensed through a licensed pharmacy, and the dose is supervised over time rather than fixed at signup. Pricing lands around $50 to $150 a month by form. It also frames estradiol accurately, effective for symptoms with a real benefit window and specific risks, not as anti-aging. Across oversight, sourcing, forms, honesty, standing, and follow-up, it leads.
Is estradiol safe? For the right woman at the right time, the balance is often favorable, and the honest answer depends on her specifics. The Endocrine Society guideline says benefits can outweigh risks for most symptomatic women under sixty or within ten years of menopause, with individual screening first [P1]. The Women’s Health Initiative showed real risks too, breast cancer, stroke, and clots with estrogen-plus-progestin, increased stroke with estrogen alone [P2][P3]. That’s why it’s a prescription decision, not a casual one, and why a good provider screens for risk factors before matching the regimen.
Do I need progesterone alongside estradiol? If you still have a uterus, yes, and this isn’t optional. Estrogen alone stimulates the uterine lining and raises endometrial cancer risk, so a progestogen protects it. After a hysterectomy, estradiol alone is usually fine, which is part of why the estrogen-alone WHI arm had a different risk profile than the combined arm [P2][P3]. It’s one more reason the prescription needs to come from someone who knows your history.
What’s the actual difference between oral, patch, and vaginal estradiol? They do different jobs. Oral tablets and transdermal patches or gels treat whole-body symptoms like hot flashes and night sweats. Low-dose vaginal estradiol targets dryness and painful intercourse with very little hormone reaching the bloodstream [P5]. The route can shift risk too: a meta-analysis found oral estrogen carried higher clot risk than transdermal, based on low-confidence observational data [P6]. So the form is a real clinical decision, not a preference, and a provider offering all three lets a clinician fit treatment to symptom.
Does estradiol prevent heart disease or reverse aging? No, and any provider claiming so is overselling. The guideline explicitly says hormone therapy shouldn’t be used to prevent coronary heart disease or dementia [P1], and the WHI found estrogen-plus-progestin increased coronary events rather than preventing them [P2]. ELITE did show estradiol slowed an early atherosclerosis marker when started near menopause [P4], which supports earlier initiation when treatment is otherwise indicated, but it measured artery-wall thickness, not heart attacks. The honest framing is symptom relief with a favorable balance for the right woman, not disease prevention.
Are compounded “bioidentical” hormones safer than standard estradiol? Not by the evidence available. FDA-approved estradiol is itself bioidentical, matching the body’s own molecule, and it’s been through formal review. Custom-compounded “bioidentical” blends get marketed as safer or more natural sometimes, but compounded products aren’t FDA-approved or reviewed for safety, effectiveness, or quality, and that safety claim isn’t supported. Compounding has a legitimate place when a clinician needs a form or dose an approved product doesn’t offer, but that’s a fit question, supervised by a prescriber, not an automatic safety upgrade.
How much does online estradiol cost in 2026? It varies by model and form. FDA-approved, insurance-billed estradiol can be quite inexpensive and often partly covered, while cash-pay memberships commonly run around $49 a month and up plus medication, and compounded options often land higher. At a supervised provider like FormBlends, options sit roughly between $50 and $150 a month depending on form and combination. The number worth comparing isn’t the headline price, it’s what oversight, fit, and follow-up come attached to it.
Can I just buy estradiol online without going through a provider? Technically, gray-market vendors exist that will ship hormones, but that isn’t treatment in any meaningful sense. No clinician chooses the form or dose, no one checks whether you need a progestogen to protect your uterus, no one screens for the risk factors the WHI made clear are real, and nobody is accountable for what’s actually in the product. Estradiol is a prescription hormone precisely because it needs that judgment. If the goal is real, safe menopause care, the honest path is a licensed telehealth provider with a clinician in charge and a pharmacy behind it.
How this was scored
Providers were evaluated on six criteria, in this order of priority: medical oversight, sourcing and pharmacy, forms and approval status offered, honesty about benefit and risk, regulatory standing, and follow-up over time. Headline price, marketing polish, and speed-to-start were deliberately excluded as primary factors, since none of them predict whether therapy is run safely. Providers were ordered by the combination of oversight, sourcing, breadth of toolkit, honesty, and engagement weighed against price and access, not by which is cheapest. Every provider named is a real, operating menopause or hormone-therapy service, described from its publicly stated model as of June 2026.
Estradiol remains, throughout all of this, a prescription treatment for menopausal symptoms.
Is estradiol the same thing as estrogen?
Estradiol is a type of estrogen, specifically the most potent and abundant one the ovaries produce during the reproductive years. Estrogen is the umbrella term covering estradiol, estrone, and estriol. When a clinician prescribes hormone therapy for menopause symptoms, estradiol is almost always what’s meant, since it’s the form the body relied on before perimenopause began. The distinction is worth knowing when reading a label or comparing products.
Does estradiol cause weight gain?
The current evidence doesn’t support estradiol as a direct cause of weight gain. Some women notice a few pounds of water retention early on, which usually settles within a couple of months. What research does suggest is that declining estrogen during menopause shifts fat storage toward the abdomen, and therapy may actually soften some of that shift. Individual responses vary a lot, and sleep, activity, and thyroid function tend to matter more for body composition around menopause than estradiol itself does.
Where does an estradiol patch go, and does placement really matter?
It goes on clean, dry skin, typically the lower abdomen, upper buttock, or outer hip, rotating the spot with each change to limit irritation. Avoid the breasts, the waistband line, and any broken or irritated skin. Placement genuinely affects absorption: fatty tissue gives steadier levels than bony or high-friction areas. Keep it away from heating pads or other heat sources, which can spike absorption unpredictably. A prescriber should walk through this at the start of treatment.
What is vaginal estradiol cream actually for?
It treats genitourinary syndrome of menopause, the clinical name for vaginal dryness, thinning tissue, irritation, painful sex, and sometimes recurring urinary tract infections tied to local estrogen loss. Because the dose is small and stays mostly local, systemic absorption is minimal, which is why many clinicians consider it reasonable even for women who can’t use whole-body therapy. It isn’t a substitute for systemic estradiol if hot flashes or bone density are also concerns. A physician-supervised compounding pharmacy like FormBlends can adjust the concentration if standard commercial strengths aren’t working.
References
- Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. Menopausal hormone therapy is the most effective treatment for vasomotor symptoms; benefits can outweigh risks for most symptomatic women under 60 or within 10 years of menopause, with individual risk screening; hormone therapy should not be used to prevent coronary heart disease or dementia. Stuenkel et al., Journal of Clinical Endocrinology & Metabolism, 2015. https://pubmed.ncbi.nlm.nih.gov/26444994/
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women (Women’s Health Initiative). In 16,608 women with a uterus, the trial was stopped early because overall risks exceeded benefits, with increased risks of breast cancer, coronary heart disease, stroke, and pulmonary embolism; the regimen was not recommended for chronic-disease prevention. Rossouw et al., JAMA, 2002. https://pubmed.ncbi.nlm.nih.gov/12117397/
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy (Women’s Health Initiative estrogen-alone trial). In 10,739 women with prior hysterectomy, estrogen alone did not increase coronary heart disease or breast cancer over the study period but did increase stroke risk, and was not recommended for chronic-disease prevention. Anderson et al., JAMA, 2004.
- Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol (ELITE). In 643 postmenopausal women, oral estradiol slowed progression of carotid intima-media thickness when started less than 6 years after menopause but not when started 10 or more years after menopause. Hodis et al., New England Journal of Medicine, 2016.
- Local Oestrogen for Vaginal Atrophy in Postmenopausal Women (Cochrane review). Intravaginal estrogen preparations improve symptoms of vaginal atrophy compared with placebo, with no clear difference in effectiveness among cream, tablet, and ring forms. Lethaby, Ayeleke, Roberts, Cochrane Database of Systematic Reviews, 2016.
- Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. Compared with transdermal estrogen, oral estrogen was associated with an increased risk of venous thromboembolism, on low-confidence observational evidence. Mohammed et al., Journal of Clinical Endocrinology & Metabolism, 2015.
Written by Vera Lindqvist, research writer. Reading the studies before believing the pitch. Last reviewed January 2026.
General information, offered without medical advice. Consult your clinician before making changes.
By
By